Heat Biologics to Present at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
DURHAM, N.C., Nov. 07, 2016 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (Nasdaq:HTBX), a leader in the development of gp96-based immunotherapies that activate a patient’s immune system to fight cancer, announced that it will present a poster on its ComPACT …